Aua Capital Management, LLC Eli Lilly & CO Transaction History

Aua Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$296.48 - $337.87 $118,592 - $135,148	-400 Reduced 43.29%	524 $169,000
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $1,672 - $1,963	-6 Reduced 0.65%	924 $300,000
Q1 2022 May 04, 2022	BUY	$234.69 - $291.66 $70,407 - $87,498	300 Added 47.62%	930 $266,000
Q4 2020 Feb 09, 2021	SELL	$130.46 - $172.63 $130 - $172	-1 Reduced 0.16%	630 $106,000
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $92,264 - $106,721	631 New	631 $93,000
Q2 2020 Jul 13, 2020	SELL	$136.42 - $164.18 $81,851 - $98,508	-600 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $29,683 - $35,040	400 Added 200.0%	600 $46,000
Q3 2017 Oct 20, 2017	BUY	$77.07 - $85.54 $15,413 - $17,108	200	200 $17,000

3,887

763M

6.34M

7.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Aua Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Aua Capital Management, LLC with notifications on news.